American Peptide Company Announces Expansion of Its GMP Manufacturing Facility
Company expands capacity to accommodate large scale peptide production for growing customer base
This two-phase expansion encompasses the construction of peptide purification and peptide synthesis suites. Four additional purification suites will be completed in the first phase and commence operation in April 2009. This addition will include new HPLC columns and tray lyophilizers.
The second phase of the construction includes two additional large-scale synthesis suites for both solution and solid phase, and completion is forecasted for Q2 in 2009. A unique component of this expansion are the 1,000 L to 2,000 L reactors for solution phase synthesis, in addition to the 260 L to 500 L SPPS for solid phase synthesis. Storage capacity will be doubled, and a 200 L tray lyophilizer will be installed to accommodate large scale production.
Other news from the department manufacturing
These products might interest you
Most read news
More news from our other portals
See the theme worlds for related content
Topic world HPLC
HPLC is a key technology in modern analytical chemistry. It enables the separation, identification and quantification of components in complex mixtures with high precision and efficiency. Whether in the analysis of active pharmaceutical ingredients, the quality control of foodstuffs or the examination of biological samples - HPLC is often the method of choice for demanding separation tasks.
Topic world HPLC
HPLC is a key technology in modern analytical chemistry. It enables the separation, identification and quantification of components in complex mixtures with high precision and efficiency. Whether in the analysis of active pharmaceutical ingredients, the quality control of foodstuffs or the examination of biological samples - HPLC is often the method of choice for demanding separation tasks.